Symbol
RNTX on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership
3.68M shares
Security Ownership
6.2%

BIOS EQUITY PARTNERS III, LP ownership in Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

2025-08-11 - BIOS EQUITY PARTNERS III, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.68M shares of Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX). This represents 6.2% percent ownership of the company.